Blog
RSS FeedPosted by Michael Wonder on 15 Aug 2022
One stop shop in Medicare shake-up
16 August 2022 - Doctors may be able to spend more time with patients, treat patients after-hours, and employ nurses, ...
Posted by Michael Wonder on 10 Aug 2022
The situation in New Zealand can only be described as dire
11 August 2022 - The available evidence for 2022 suggests the innovative pharmaceutical industry has very little interested in preparing/lodging ...
Posted by Michael Wonder on 05 Aug 2022
Health Minister Mark Butler ‘terrified’ of low GP numbers as bulk billing declines
6 August 2022 - Federal Health Minister Mark Butler has acknowledged there will be “terrible consequences” if general practice continues ...
Posted by Michael Wonder on 04 Aug 2022
Bulk billing ‘on verge of collapse’
5 August 2022 - Doctors have warned that the nation is facing the “collapse of bulk billing” in general practice, ...
Posted by Michael Wonder on 03 Aug 2022
FDA approves Coherus’ Cimerli (ranibizumab-eqrn) as the first and only interchangeable biosimilar to Lucentis for all five indications, with 12 months of interchangeability exclusivity
2 August 2022 - First Cimerli product sales expected in October 2022. ...
Posted by Michael Wonder on 26 Jul 2022
Lowest drug plan premium does not always mean lowest cost for you
26 July 2022 - Before Medicare, you probably had coverage through an employer group health plan. ...
Posted by Michael Wonder on 21 Jun 2022
Medicare could’ve saved $3.6 billion by buying drugs at same prices as Mark Cuban’s online pharmacy, according to a new study
22 June 2022 - Medicare’s drug program could have saved up to $3.6 billion in 2020 by mirroring the pricing ...
Posted by Michael Wonder on 17 Jun 2022
NICE recommends new targeted treatment for early breast cancer
16 June 2022 - NICE has provisionally approved a new treatment for early breast cancer that it says will benefit ...
Posted by Michael Wonder on 30 May 2022
Why won’t the FDA let doctors prescribe fluvoxamine for COVID?
30 May 2022 - Trials show it keeps patients from getting sicker, but the agency won’t approve its emergency use. ...
Posted by Michael Wonder on 27 May 2022
Medicare premium increase from Alzheimer’s drug to be lowered next year
27 May 2022 - Health and Human Services Secretary Xavier Becerra announced on Friday that Medicare premiums would be adjusted ...
Posted by Michael Wonder on 25 May 2022
Medicare spending on drugs with accelerated approval
24 May 2022 - The U.S. FDA provides accelerated approval to drugs on the basis of surrogate end points deemed to ...
Posted by Michael Wonder on 18 May 2022
CMS unveils more user friendly Medicare website
18 May 2022 - New Medicare.gov will incorporate public feedback and make it easier to compare, choose, and understand Medicare ...
Posted by Michael Wonder on 12 May 2022
Federal investigators find Medicare Advantage plans too often deny, delay needed care
10 May 2022 - Medicare Advantage plans that provide health insurance coverage to millions of US seniors deny some medically ...
Posted by Michael Wonder on 09 May 2022
The Center for Medicare and Medicaid Innovation - toward value based care
9 May 2022 - Before the enactment of the Patient Protection and Affordable Care Act in 2010, experimentation with Medicare or ...
Posted by Michael Wonder on 05 May 2022
Aadi Bioscience announces unique permanent J code issued for Fyarro from Centers for Medicare and Medicaid Services
4 May 2022 - Effective 1 July J code will enable a streamlined reimbursement process for Fyarro. ...